Bath & Body Works (NYSE:BBWI) Issues Q1 Earnings Guidance

Bath & Body Works (NYSE:BBWI - Get Free Report) updated its first quarter earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $0.36-0.43 for the period, compared to the consensus estimate of $0.42. Bath & Body Works also updated its FY26 guidance to $3.25-360 EPS.

Bath & Body Works Trading Down 6.6 %

Shares of BBWI opened at $30.45 on Tuesday. The company has a market cap of $6.60 billion, a price-to-earnings ratio of 7.43, a P/E/G ratio of 0.92 and a beta of 1.89. The business's fifty day simple moving average is $37.09 and its two-hundred day simple moving average is $34.14. Bath & Body Works has a 12 month low of $26.20 and a 12 month high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The company reported $2.09 EPS for the quarter, beating the consensus estimate of $2.04 by $0.05. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The company had revenue of $2.79 billion for the quarter, compared to analysts' expectations of $2.78 billion. As a group, research analysts forecast that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were issued a dividend of $0.20 per share. The ex-dividend date was Friday, February 21st. This represents a $0.80 annualized dividend and a dividend yield of 2.63%. Bath & Body Works's payout ratio is 21.98%.

Remove Ads

Bath & Body Works announced that its board has approved a share repurchase program on Thursday, February 27th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to buy up to 6.4% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's management believes its stock is undervalued.

Analyst Ratings Changes

A number of research analysts have weighed in on the company. Cowen reissued a "buy" rating on shares of Bath & Body Works in a report on Thursday, February 27th. Robert W. Baird upped their price target on shares of Bath & Body Works from $45.00 to $47.00 and gave the company an "outperform" rating in a research report on Friday, February 28th. Wells Fargo & Company raised shares of Bath & Body Works from an "equal weight" rating to an "overweight" rating and raised their price objective for the stock from $42.00 to $48.00 in a report on Friday, January 10th. Telsey Advisory Group restated an "outperform" rating and set a $43.00 target price on shares of Bath & Body Works in a research report on Thursday, February 27th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a "buy" rating in a research report on Tuesday, November 26th. Five equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $45.06.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.